Dr. Greiner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1051 Riverside Dr
New York, NY 10032Phone+1 646-774-6492
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 2016 - 2020
University of Kansas School of MedicineClass of 2016
Columbia University Mailman School of Public HealthMPH, Health Policy and Management, 2014 - 2015
Certifications & Licensure
NY State Medical License 2017 - 2026- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
Publications & Presentations
PubMed
- Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial.Matisyahu Shulman, Miranda G Greiner, Hiwot M Tafessu, Onumara Opara, Kaitlyn Ohrtman
JAMA Network Open. 2024-05-01 - Commentary on Foot et al.: Clinical considerations in addressing comorbid stimulant use in opioid use disorder.Matisyahu Shulman, Miranda Greiner, Adam Bisaga
Addiction. 2024-01-01 - 2 citationsSurmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study.Miranda G Greiner, Matisyahu Shulman, Onumara Opara, Kenzie Potter, Delia C Voronca
Contemporary Clinical Trials. 2023-05-01
Press Mentions
From the Front Line: Trainees’ Perspective on Providing Care During COVID-19 PandemicApril 27th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
